Regatta Research & Money Management’s Pfizer PFE Stock Holding History

Regatta Research & Money Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364K	Buy	+15,106	New	+$395K	0.34%	57

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Regatta Research & Money Management's PFE Position: Q2 2026 in Review

Regatta Research & Money Management opened a new position in Pfizer (PFE) in Q2 2026: 15,106 shares worth $364K. The stake represents 0.34% of the portfolio and ranks #57 among its holdings.

2,305 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Regatta Research & Money Management held 15,106 shares of Pfizer worth $364K as of Q2 2026.
Pfizer was a new Regatta Research & Money Management position in Q2 2026.
Pfizer made up 0.34% of Regatta Research & Money Management's portfolio in Q2 2026, its #57 holding.
2,305 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Regatta Research & Money Management's 13F filing for Q2 2026, filed 12 Aug 2026.